The first of what is expected to be many lawsuits against Bayer Corp., maker of the clotting drug Trasylol, has been filed in Missouri, the St. Louis Daily Record reports.
The suit was filed on March 10 by the St. Louis-based based Carey & Danis on behalf of a widow, Genevieve Nakis, whose husband died of kidney failure after open-heart surgery. The Lowe Law Firm, also of St. Louis, is working of counsel on the case.
On Dec. 16, 2005, Samuel Nakis, 81, underwent open-heart surgery at St. Luke’s Hospital in Chesterfield, Mo. During the surgery he was given Trasylol (also known as aprotinin), a clotting drug used to prevent bleeding. Shortly after the surgery, Nakis experienced kidney failure and underwent dialysis. He died a short time later.
In an interview with reporter Donna Walter, Joseph Danis said, “Knowledge is the key factor. We have to prove that Bayer knew of the risks and should have warned of them.”
That’s a standard the attorneys believe they can meet. In addition to recently released studies linking Trasylol to kidney failure and death, Jeff Lowe notes, “There have been reports of problems going back quite a bit even before it was on the market in the United States.”
According to the front-page story, which appeared in the March 13 issue of the Record, about 25 plaintiffs have signed up as Carey & Danis clients to pursue claims against Bayer involving Trasylol.